Correlation Between Verizon Communications and Fusion Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Verizon Communications and Fusion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verizon Communications and Fusion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verizon Communications and Fusion Pharmaceuticals, you can compare the effects of market volatilities on Verizon Communications and Fusion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verizon Communications with a short position of Fusion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verizon Communications and Fusion Pharmaceuticals.

Diversification Opportunities for Verizon Communications and Fusion Pharmaceuticals

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Verizon and Fusion is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Verizon Communications and Fusion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fusion Pharmaceuticals and Verizon Communications is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verizon Communications are associated (or correlated) with Fusion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fusion Pharmaceuticals has no effect on the direction of Verizon Communications i.e., Verizon Communications and Fusion Pharmaceuticals go up and down completely randomly.

Pair Corralation between Verizon Communications and Fusion Pharmaceuticals

Allowing for the 90-day total investment horizon Verizon Communications is expected to generate 0.29 times more return on investment than Fusion Pharmaceuticals. However, Verizon Communications is 3.4 times less risky than Fusion Pharmaceuticals. It trades about 0.07 of its potential returns per unit of risk. Fusion Pharmaceuticals is currently generating about -0.37 per unit of risk. If you would invest  3,088  in Verizon Communications on September 12, 2024 and sell it today you would earn a total of  1,142  from holding Verizon Communications or generate 36.98% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy1.14%
ValuesDaily Returns

Verizon Communications  vs.  Fusion Pharmaceuticals

 Performance 
       Timeline  
Verizon Communications 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verizon Communications has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Verizon Communications is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Fusion Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fusion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Fusion Pharmaceuticals is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Verizon Communications and Fusion Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Verizon Communications and Fusion Pharmaceuticals

The main advantage of trading using opposite Verizon Communications and Fusion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verizon Communications position performs unexpectedly, Fusion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fusion Pharmaceuticals will offset losses from the drop in Fusion Pharmaceuticals' long position.
The idea behind Verizon Communications and Fusion Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Global Correlations
Find global opportunities by holding instruments from different markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated